LISATA THERAPEUTICS, INC. Other Non-Current Liabilities
LISATA THERAPEUTICS, INC. (LSTA) had Other Non-Current Liabilities of $50.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Liabilities, Noncurrent $50.00K.
- 2026-03-31: Other Liabilities, Noncurrent $72.00K.
- 2025-12-31: Other Liabilities, Noncurrent $72.00K.
- 2025-09-30: Other Liabilities, Noncurrent $72.00K.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $50.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $72.00K 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $72.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $72.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $72.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $72.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $72.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $72.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $119.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $164.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $210.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $253.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $295.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $337.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $327.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | $367.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $383.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $421.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $485.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $53.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $79.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $155.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $254.00K 10-K · filed 2022-03-22 | |
| 2020-09-30 | $351.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $445.00K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $536.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $624.00K 10-K · filed 2021-02-25 | |
| 2019-09-30 | $710.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $1.02M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.73M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.51M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $2.15M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $2.80M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $3.44M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $3.87M 10-K · filed 2019-03-14 | $3.87M 10-K · filed 2018-03-22 |
| 2017-09-30 | $3.20M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $3.64M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $407.24K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $389.86K 10-K · filed 2018-03-22 | |
| 2016-09-30 | $370.08K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $508.59K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $432.80K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $562.00K 10-K · filed 2017-03-17 | |
| 2015-09-30 | $3.46M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $3.47M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $930.36K 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $804.55K 10-K · filed 2016-03-15 | |
| 2014-09-30 | $616.00K 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $635.01K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $635.01K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $598.73K 10-K · filed 2015-03-02 | |
| 2013-09-30 | $511.89K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $383.11K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $275.35K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $214.87K 10-K · filed 2014-03-13 | |
| 2012-09-30 | $139.28K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $70.53K 10-Q · filed 2012-08-14 | |
| 2011-12-31 | $0.00 10-K · filed 2013-03-11 | |
| 2011-01-19 | $540.50K 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |